Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
Sponsor: Sun Pharmaceutical Industries Limited
Summary
to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment
Official title: Histologic and Liquid Chromatography Mass Spectrometry (LCMS) Evaluation of the Sebaceous Gland Changes Induced by Clascoterone Cream 1%
Key Details
Gender
All
Age Range
18 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-07-01
Completion Date
2026-03
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Winlevi (Clascoterone) cream 1%
Dosed twice daily (BID)
Locations (1)
Dermatology Consulting Services, PLLC
High Point, North Carolina, United States